| 1 | [SID124753859] | Active | Potency | 8.1995 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | Potency | 8.1995 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID124753859] | Active | Potency | 16.3601 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | Potency | 16.3601 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID124753859] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID124753859] | Active | Potency | 31.6228 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 5 | [SID124753859] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) [AID624467, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624467 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 6 | [SID124753859] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) [AID624467, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624467 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 7 | [SID124753859] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) [AID624466, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624466 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 8 | [SID124753859] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) [AID624466, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624466 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 9 | [SID124753859] | Active | | | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) [AID624268, Type: screening] | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) | | AID | 624268 | | BioAssay type | screening | | Target | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] | | PubMed | | | Data Table |  |
|
| 10 | [SID124753859] | Active | | | Luminescence-based biochemical high throughput confirmation assay for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) [AID624412, Type: screening] | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | Luminescence-based biochemical high throughput confirmation assay for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) | | AID | 624412 | | BioAssay type | screening | | Target | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] | | PubMed | | | Data Table |  |
|
| 11 | [SID124753859] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 12 | [SID124753859] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 13 | [SID124753859] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 14 | [SID124753859] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624127, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624127 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 15 | [SID124753859] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624127, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624127 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 16 | [SID124753859] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624127, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624127 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 17 | [SID124753859] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 18 | [SID124753859] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 19 | [SID124753859] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 20 | [SID124753859] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 21 | [SID124753859] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 22 | [SID124753859] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 23 | [SID124753859] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 24 | [SID124753859] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 25 | [SID124753859] | Active | | | uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay [AID602449, Type: screening] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay | | AID | 602449 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID124753859] | Active | | | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set [AID624256, Type: screening] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set | | AID | 624256 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID124753859] | Active | | | Counterscreen for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS): Luminescence-based cell-based high throughput assay to identify compounds that are cytotoxic to Jurkat human T lymphocyte cells [AID624413, Type: screening] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS): Luminescence-based cell-based high throughput assay to identify compounds that are cytotoxic to Jurkat human T lymphocyte cells | | AID | 624413 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID124753859] | Active | | | Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line [AID602248, Type: screening] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line | | AID | 602248 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID124753859] | Active | | | Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line [AID602250, Type: screening] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line | | AID | 602250 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID124753859] | Active | | | Single concentration confirmation of uHTS inhibitor hits of the mitochondrial permeability transition pore via a fluorescent based assay [AID624504, Type: screening] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS inhibitor hits of the mitochondrial permeability transition pore via a fluorescent based assay | | AID | 624504 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID124753859] | Inactive | | | HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity [AID651610, Type: screening] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Inactive | | BioAssay | HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651610 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID124753859] | Inactive | | | DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity [AID651640, Type: screening] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Inactive | | BioAssay | DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity | | AID | 651640 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID124753859] | Inactive | | | Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity [AID651661, Type: screening] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651661 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID124753859] | Inactive | | | Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library [AID651702, Type: screening] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Inactive | | BioAssay | Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library | | AID | 651702 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID124753859] | Inactive | | | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats [AID651821, Type: screening] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats | | AID | 651821 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID124753859] | Inactive | | | uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay [AID651999, Type: screening] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay | | AID | 651999 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID124753859] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 [AID652010, Type: screening] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 | | AID | 652010 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID124753859] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM) [AID652017, Type: screening] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM) | | AID | 652017 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID124753859] | Inactive | Potency | | qHTS of IL-2 Activators [AID652025, Type: confirmatory] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of IL-2 Activators | | AID | 652025 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID124753859] | Inactive | | | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen [AID652039, Type: screening] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Inactive | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 652039 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID124753859] | Inactive | Potency | | qHTS of TDP-43 Inhibitors [AID652104, Type: confirmatory] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of TDP-43 Inhibitors | | AID | 652104 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID124753859] | Inactive | | | uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells [AID602274, Type: screening] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Inactive | | BioAssay | uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells | | AID | 602274 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID124753859] | Inactive | | | Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line [AID602247, Type: screening] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Inactive | | BioAssay | Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line | | AID | 602247 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID124753859] | Inactive | | | Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease [AID624483, Type: screening] | |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Inactive | | BioAssay | Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease | | AID | 624483 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 45 | [SID124753859] | Inactive | Potency | | qHTS of alpha-syn Inhibitors [AID652106, Type: confirmatory] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of alpha-syn Inhibitors | | AID | 652106 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID124753859] | Inactive | | | MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5 [AID652115, Type: screening] | |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Inactive | | BioAssay | MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5 | | AID | 652115 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 47 | [SID124753859] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID124753859] | Inactive | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID124753859] | Inactive | | | HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity [AID652154, Type: screening] | |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Inactive | | BioAssay | HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652154 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 50 | [SID124753859] | Inactive | | | S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity [AID652163, Type: screening] | |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 124753859 | | CID | 53299872 | | Outcome | Inactive | | BioAssay | S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652163 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|